Viewing stories tagged investor
9 August 2017 Starpharma and Monash awarded STEM+ Business Fellowships
7 August 2017 Successful VivaGel® Phase 3 results and NDA planned for rBV
4 July 2017 Shareholder Update July 2017
14 June 2017 Sale of Agrochemicals Business Investor Presentation
14 June 2017 Starpharma sells Agrochemicals business to Agrium for $35M
6 June 2017 DEP® irinotecan outperforms irinotecan in multiple cancer models
20 April 2017 AstraZeneca DEP® candidate advance triggers milestone to Starpharma
12 April 2017 Ansell launches VivaGel® condom in Canada
30 March 2017 VivaGel® BV phase 3 trials for prevention of BV completed
12 January 2017 VivaGel® BV granted QIDP and Fast Track designation by US FDA